SE8501613D0 - Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling - Google Patents

Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Info

Publication number
SE8501613D0
SE8501613D0 SE8501613A SE8501613A SE8501613D0 SE 8501613 D0 SE8501613 D0 SE 8501613D0 SE 8501613 A SE8501613 A SE 8501613A SE 8501613 A SE8501613 A SE 8501613A SE 8501613 D0 SE8501613 D0 SE 8501613D0
Authority
SE
Sweden
Prior art keywords
therapeutic
associations
procedures
compound
diagnostic application
Prior art date
Application number
SE8501613A
Other languages
English (en)
Swedish (sv)
Original Assignee
Bio Carb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Carb Ab filed Critical Bio Carb Ab
Priority to SE8501613A priority Critical patent/SE8501613D0/xx
Publication of SE8501613D0 publication Critical patent/SE8501613D0/xx
Priority to EP86902540A priority patent/EP0217912A1/en
Priority to PCT/SE1986/000131 priority patent/WO1986005789A1/en
Priority to AU56682/86A priority patent/AU5668286A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8501613A 1985-04-01 1985-04-01 Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling SE8501613D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE8501613A SE8501613D0 (sv) 1985-04-01 1985-04-01 Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
EP86902540A EP0217912A1 (en) 1985-04-01 1986-03-25 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
PCT/SE1986/000131 WO1986005789A1 (en) 1985-04-01 1986-03-25 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use
AU56682/86A AU5668286A (en) 1985-04-01 1986-03-25 Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8501613A SE8501613D0 (sv) 1985-04-01 1985-04-01 Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Publications (1)

Publication Number Publication Date
SE8501613D0 true SE8501613D0 (sv) 1985-04-01

Family

ID=20359733

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501613A SE8501613D0 (sv) 1985-04-01 1985-04-01 Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Country Status (4)

Country Link
EP (1) EP0217912A1 (xx)
AU (1) AU5668286A (xx)
SE (1) SE8501613D0 (xx)
WO (1) WO1986005789A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582758B2 (en) * 1984-06-28 1989-04-13 Mect Corporation Sialic acid derivatives, galactose derivatives and method for producing the same
FR2640628A1 (fr) * 1988-12-16 1990-06-22 Commissariat Energie Atomique Oligosaccharides lies (beta)-(1 -> 6) en particulier des 2-acetamido-2-desoxy-glucoses ou - galactoses et leur preparation
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
FR2663636B1 (fr) * 1990-06-26 1992-10-09 Centre Nat Rech Scient Procede de fonctionnalisation d'un oligonucleotide.
DE69110906T2 (de) * 1990-12-21 1995-11-16 Microcarb Inc Verwendung von Wirtszellphospholipiden zur Hemmung bakterieller Besiedlung.
CA2114629C (en) * 1991-07-31 2003-01-14 Howard C. Krivan Receptor conjugates for targeting antibiotics to bacteria
JP2894879B2 (ja) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 診断用造影剤
NZ536331A (en) 2002-05-09 2007-08-31 Hemoteq Ag Compounds and method for coating surfaces of medical devices such as stents in a haemocompatible manner
DE10261986B4 (de) * 2002-05-10 2008-01-31 Hemoteq Ag Hämokompatibel beschichtete Oberflächen, Verfahren zu deren Herstellung und deren Verwendungen
WO2013051597A1 (ja) 2011-10-04 2013-04-11 塩野義製薬株式会社 カテコール基を有するセフェム誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155575A (en) * 1960-12-16 1964-11-03 Warner Lambert Pharmaceutical Composition for inhibiting pepsin activity and method of preparing same
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3911116A (en) * 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3914413A (en) * 1971-02-10 1975-10-21 Leslie L Balassa Process for facilitating wound healing with N-acetylated partially depolymerized chitin materials
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) * 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
DE3347163A1 (de) * 1983-12-27 1985-07-04 Behringwerke Ag, 3550 Marburg Verwendung von oligosacchariden zur chemotherapie oder chemoprophylaxe der malaria
DE3402739A1 (de) * 1984-01-27 1985-08-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen den glycanstrang des peptidoglycans, verfahren und reagenzien zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung

Also Published As

Publication number Publication date
WO1986005789A1 (en) 1986-10-09
AU5668286A (en) 1986-10-23
EP0217912A1 (en) 1987-04-15

Similar Documents

Publication Publication Date Title
DE3681517D1 (de) Thiazolidinderivate, verfahren zu deren herstellung und deren anwendung.
SE7901099L (sv) Piperazinderivat
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
ES2051753T3 (es) N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
SE8501613D0 (sv) Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8604950D0 (sv) Dementia-improving and therapeutic agents
ES2014482B3 (es) Nuevas 2-tiazolil imidazo/1,2-a/pirimidinas y sus sales, su procedimiento de preparacion, su aplicacion a titulo de medicamentos y las composiciones que las encierran.
GR71207B (xx)
ATE153666T1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
AR241422A1 (es) Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas.
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.
DE68928767D1 (de) Imido-percarbonsäuren
ATE56436T1 (de) Diselenobisbenzoesaeureamide primaerer heterocyclischer amine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
SE8406338D0 (sv) 4,5,6,7-tetrahydrotiazolo/5,4-c/-pyridinderivat
ATE57T1 (de) 4,5-methano-bufadienolid-rhamnoside, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DK47082A (da) Fremgangsmaade til fremstilling af bis- og polydisulfider
ATE42287T1 (de) Homocysteinthiolactonderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE15667T1 (de) Neue substituierte 3,5-diamino-1,2,4-oxadiazole und 3,5-diamino-1,2,4-thiadiazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
PT83975B (pt) Processo para a preparacao de derivados de 5-aminoalquil-beta-carbolinas e de composicoes farmaceuticas que os contem
EP0223647A3 (en) Alkyl carboxamides of pyridyl alkyl amines, their preparation and their use as medicaments
ES517673A0 (es) Procedimiento para la preparacion de cetales de 3'-deshidro -cardenolido-tridigitoxosidos.
NO922094L (no) Heksapeptider med sulfatestergrupper
DK523482A (da) Oximer af 3'''-dehydro-kardenolid-tridigitoxosider, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ATE9091T1 (de) Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.